24 May 2013
Keywords: akela, sees, positive, ph, ii, results, its
Article | 19 November 2007
Akela Pharma, a Canadian drug development company focused on therapies for the inhalation and pain markets, has announced positive final
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 November 2007
12 November 2007
23 May 2013
© 2013 thepharmaletter.com